COVID-19 Update

Our primary concern is the safety of all our study participants and minimising any additional strain on our clinical sites and staff.

The COVID-19 pandemic is affecting people and health services around the world. Our primary concern is the safety of all our study participants and minimising any additional strain on our clinical sites and staff. We are working closely with our clinical sites and partner organisations to find ways of doing this. Please contact the relevant trial team via the trial email address if you have questions about what this means for a specific study.

We are working on developing several studies looking at COVID-19, including the ACTT- EU/UK trial. We hope to open this study in April 2020. It will test drugs to treat people in hospital due to the virus. The adaptive design will allow us to add new treatment comparisons as new potential ways to treat the disease are discovered.

Latest News and Updates

ACTT-EU/UK: publication of trial results showing remdesivir speeds up COVID-19 recovery

An international clinical trial testing the effectiveness of the drug remdesivir on patients hospitalised with COVID -19, has shown “very promising” preliminary results.

26 May

Di Gibb elected a Fellow of the Academy of Medical Sciences

She is one of 50 of the UK's leading figures within biomedical and health sciences to be elected to the esteemed Fellowship.

18 May

ACTT-EU/UK trial finds remdesivir speeds up COVID-19 recovery

An international clinical trial that is testing the effectiveness of the drug remdesivir on patients hospitalised with Covid-19, has shown “very promising” preliminary results.

30 Apr

Tribute to Lynda Harper

We are all so sad at the Unit about losing our beloved colleague Lynda Harper on 14 April. She was indeed one of the most generous, kind, selfless and wonderful people and we all miss her so much.

21 Apr

Our Research Themes

Cancer

Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types

Infections

Major international clinical trials answering questions of global public health significance

Methodology

Development of methods with direct impact on the design, conduct and analysis of studies

Other Research & Policy

This section will capture projects outside the current QQR themes

Our Latest Tweets

MRC CTU at UCL MRCCTU

An international clinical trial testing the effectiveness of the drug #remdesivir on patients hospitalised with #COVID19, has shown “very promising” preliminary results. Read more here: https://t.co/LuuLBCTqk4

May 26
MRC CTU at UCL MRCCTU

@NHSDigital is the largest releaser of data to clinical trials in the UK https://t.co/F8SonpllYT

May 22
MRC CTU at UCL MRCCTU

160 RCTs successfully accessed UK registry data between 2013 and 2018 to inform or supplement trial data. For almost half, the registry data informed the primary trial outcome measure https://t.co/F8SonpllYT #nhsdigital, #ehr #trialconduct #clinicaltrials

May 20